A.I. Virtanen Institute for Molecular Sciences - News

A novel angiogenic microRNA drug can be a new option for the treatment of ischemic cardiovascular disease.

Malm’s funding is the first ever ERC Consolidator Grant granted by the ERC Neuroscience panel to a Finnish researcher.

The university has opened another call for applications for Proof of Concept (PoC) funding to accelerate the commercialisation of research-based ideas. For Professor Tarja Malm, PoC projects have opened several doors.

The new cell model for Alzheimer’s disease is based on patient-derived cells of the olfactory mucosa, located in the upper parts of the nasal cavity.

Using patient-derived iPSC models, the PhD study identified several gene and protein expressional changes associated with clinical manifestation and increased risk to develop schizophrenia.

“Coronary artery disease has, for a long time, been mainly treated with cholesterol-lowering drugs, but there is a need for other types of treatments as well. For example, new drugs could target pathogenic changes taking place in the arterial wall,” Professor Minna Kaikkonen-Määttä says.

Hexanucleotide repeat expansion in the C9orf72 gene leads to structural and functional changes in synapses that connect neurons, a new study shows.

The awards ceremony was held on 16 December at Kuopio Campus.

The University of Eastern Finland participates in six of the funded FIRI consortia, and funding for the development of infrastructures was granted to all faculties of the university.